Paper Details

  1. Home
  2. Paper Details

Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review.

Author: PutraOki Nugraha, SoedarsonoSoedarsono, SubaySusi, YulistianiYulistiani

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Drug-resistant tuberculosis (DR-TB) is a serious health problem that's difficult to treat. New drugs like bedaquiline and delamanid have shown promise in treating DR-TB, leading to better outcomes for patients, including reduced mortality and faster recovery.
Paper Details　
Original Abstract of the Article :
Drug-resistant tuberculosis (DR-TB) is a public health concern that is difficult to treat, requiring long and complex treatment with highly effective drugs. Bedaquiline and/or delamanid have already shown promising outcomes in patients with DR-TB, increasing the rate of culture conversion and loweri...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.4103/ijmy.ijmy_217_22

データ提供：米国国立医学図書館（NLM）

Drug-Resistant Tuberculosis: A New Weapon in the Arsenal

Drug-resistant tuberculosis (DR-TB) is a formidable foe, challenging healthcare professionals around the world. This research delves into the effectiveness of two new drugs, bedaquiline and delamanid, in treating DR-TB. It's like discovering a new weapon in the arsenal, a powerful tool to combat this deadly disease.

Bedaquiline and Delamanid: A Promising Combination

The study reviews existing research on the use of bedaquiline and delamanid in treating DR-TB. The results show that these drugs are highly effective in converting patients to a negative TB culture, reducing the risk of mortality. It's like finding a potent antidote that effectively neutralizes the poison of DR-TB.

Hope on the Horizon for TB Treatment

This research provides a beacon of hope for patients battling DR-TB. It's like discovering a hidden oasis in the vast desert of TB treatment challenges. The study's findings suggest that bedaquiline and delamanid are powerful weapons in the fight against DR-TB, offering new hope for a cure and a healthier future for patients.

Dr.Camel's Conclusion

This research sheds light on the effectiveness of bedaquiline and delamanid in treating DR-TB, a serious and challenging disease. It's like discovering a new and powerful weapon in the fight against this deadly foe. The study's findings offer hope for a healthier future for patients with DR-TB, providing new pathways towards a cure and a world free from this insidious disease.

Date :
  1. Date Completed 2023-03-20
  2. Date Revised 2023-03-30
Further Info :

Pubmed ID

36926755

DOI: Digital Object Identifier

10.4103/ijmy.ijmy_217_22

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.